KE

Kimball is a thin-margin contract electronics manufacturer deep in a cyclical downturn. FY2025 revenue fell 13.3% to $1.49B — the third straight year of decline off the FY2023 peak of $1.82B — with every vertical shrinking: automotive -11% (loss of a major program plus end-of-life programs), medical -7% (customer inventory overstocking), and industrial -24% (GES divestiture, plus smart-metering programs losing share to commoditization). Gross margin compressed to 7.0% from 8.2% on 'lost absorption on lower revenue,' net income slipped to $17.0M, and ROE is a weak 3.0%. On earnings the stock looks expensive at a 36.9x P/E — but that multiple is on trough EPS of $0.68 depressed by an $11.0M restructuring charge (Tampa closure, headcount) that is precisely the cost-structure realignment a turnaround needs.

The offsetting story is the balance sheet and cash. Long-term debt was cut roughly in half to $147M, equity rose 5.4% to $570M, and liabilities/equity sits at a comfortable 0.37x with $88.8M cash. Operating cash flow jumped 151% to $184M and, against ~$33M capex, implies ~$150M free cash flow — so the $608M market cap is only ~4x FCF and ~1.07x book value ($23.55/share). Management is returning capital (buybacks up to $12M) and lower interest expense ($14.7M vs $22.8M) reflects the de-levering.